Zoran Culig
机构: Professor of Experimental Urology, Medical University of Innsbruck
主页: zculig.org
每年引用次数
引用次数
引用: 19,060
H-指数: 74
I10-指数 : 176
出版物: 377
Prostatakarzinom - Epidemiologie in Österreich, Risikofaktoren, Pathologie, hormonelle Regulation und Tumorbiologie
Madersbacher S , Vutuc C , Culig Z , Haidinger G
Journal für Urologie und Urogynäkologie 17 ( 2) 12 -20
2010
Hyperactive androgen receptor in prostate cancer, what does it mean for new therapy concepts?
Radmayr C , Hobisch A , Cato Ac , Bartsch G
Histology and Histopathology 12 ( 3) 781 -786
19
1997
419: Growth of the Prostate Cancer Xenograft Lncap-IL-6+ is Inhibited by an Anti-Interleukin-6 Monoclonal Antibody
Hannes Steiner , Ilaria T.R. Cavarretta , Andreas P. Berger , Jasmin Bektic
The Journal of Urology 173 114 -114
2005
Interleukin-6 and prostate cancer progression
P SMITH , A HOBISCH , D LIN , Z CULIG
Cytokine & Growth Factor Reviews 12 ( 1) 33 -40
236
2001
MECHANISM OF PROSTATE-CANCER DISSEMINATION-SMALL-CELL ADENOCARCINOMA
M TARLE , Z CULIG , K KOVACIC , S SPAVENTI
PERIODICUM BIOLOGORUM 91 ( 4) 411 -414
1990
FREE PROLACTIN RECEPTORS AND SERUM TUMOR-MARKERS IN A POSSIBLE CONVERSION OF DORMANT PROSTATIC TUMORS TO THE CLINICALLY MANIFEST CANCER
M TARLE , Z ANZULOVIC , Z CULIG , D JEZEK
ANTICANCER RESEARCH 8 ( 5) 1109 -1109
1988
ELEVATED LEVELS OF SERUM SECRETONEURIN IN PATIENTS WITH THERAPY RESISTANT CARCINOMA OF THE PROSTATE
RUDOLF ISCHIA , ALFRED HOBISCH , RICHARD BAUER , ULRIKE WEISS
The Journal of Urology 163 ( 4) 1161 -1165
34
2000
Androgen Receptors in Prostate Cancer
ZORAN CULIG , HELMUT KLOCKER , GEORG BARTSCH , HANNES STEINER
The Journal of Urology 170 ( 4) 1363 -1369
74
2003
THE ROLE OF THE ANDROGEN RECEPTOR IN THE PATHOPHYSIOLOGY OF PROSTATE CANCER
ZORAN CULIG , JOSE D DEBES , GEORG BARTSCH , DONALD J TINDALL
Comprehensive Textbook of Genitourinary Oncology 31 -31
2006
CANCER STEM CELLS
ZORAN CULIG , MARCO G CECCHINI , ELIZABETH D WILLIAMS , GEORGE N THALMANN
Proinflammatory cytokine interleukin-6 in prostate carcinogenesis.
Zoran Culig
American journal of clinical and experimental urology 2 ( 3) 231 -238
36
2014
Launching of american journal of clinical and experimental urology.
Martha K Terris , Christian O Twiss , Peng Lee , Pete S Nelson
American journal of clinical and experimental urology 1 ( 1) 1 -2
2013
American Journal of Clinical and Experimental Urology: Editorial Board (2013) e-Century Publishing Corporation.
Peter S Nelson , Peng Lee , Martha K Terris , Zoran Culig
American journal of clinical and experimental urology 1 ( 1) 83 -84
2013
Interleukin-6 Regulates Prostate-specific Protein Expression in Prostate Carcinoma Cells by Activation of the Androgen Receptor
Wolfgang Horninger , Alfred Hobisch , Thomas Putz , Iris E. Eder
Cancer Research 58 ( 20) 4640 -4645
394
1998
Distant Metastases from Prostatic Carcinoma Express Androgen Receptor Protein
Christian Radmayr , Alfred Hobisch , Georg Bartsch , Anton Hittmair
Cancer Research 55 ( 14) 3068 -3072
259
1995
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
Christian Radmayr , Alfred Hobisch , Jan Trapman , Georg Bartsch
Cancer Research 54 ( 20) 5474 -5478
867
1994
Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Claudia Nessler-Menardi , Thomas Putz , Iris E. Eder , Georg Bartsch
Cancer Research 59 ( 1) 227 -233
160
1999
Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells
Sonia Godoy-Tundidor , Alfred Hobisch , Karina Pfeil , Georg Bartsch
Clinical Cancer Research 8 ( 7) 2356 -2361
27
2002
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
Sonia Godoy-Tundidor , Reinhold Ramoner , Alfred Hobisch , Dietmar Fuchs
Clinical Cancer Research 7 ( 9) 2941 -2948
150
2001
High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer
Pekka Kohonen , Vidal Fey , Kristiina Iljin , Olli Kallioniemi
Journal of Molecular Biochemistry 5 ( 1) 12 -22
7
2016